4.7 Letter

Does ruxolitinib improve survival of persons with MPN-associated myelofibrosis? Should it?

Journal

LEUKEMIA
Volume 28, Issue 11, Pages 2267-2270

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2014.220

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available